Exel Composites’ Shareholders’ Nomination Board’s

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Exel Composites’ Shareholders’ Nomination Board’s proposal for composition and remuneration of the Board of Directors

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE                  1 February 2016 at 4.45 p.m. Exel Composites’ Shareholders’ Nomination Board’s proposal for composition and remuneration of the Board of Directors Composition of the Board of Directors The Shareholders’ Nomination Board elected by the Annual General Meeting of Exel Composites Plc proposes to the Annual General Meeting to be held on 17 March 2016 that the current members of the Board of Directors, Heikki Hiltunen, Matti Hyytiäinen and Reima Kerttula be re-elected as members of the Board for the term ending at the closure of the Annual General Meeting of 2017. The Nomination Board also proposes that Jouko Peussa and Petri Helsky be elected as new members of the Board of Directors.

Jouko Peussa (58) is currently Engineering & Technology Director of Ingersoll Rand Compression Technologies. Ingersoll Rand is an international company with a turnover of USD 12.9 billion. Jouko Peussa has served Ingersoll Rand in various senior management positions. He is a Licenciate of Technology.

Petri Helsky (49) is currently CEO of Metsä Tissue. Metsä Tissue is an international company producing tissue paper and baking and cooking paper with a turnover of some EUR 1 billion. Previously Petri Helsky has served Kemira in several senior management positions. He holds an M.Sc. in Economics and an M.Sc. in Engineering. 

Peter Hofvenstam (Chairman of the Board since 2008 and member of the Board since 2001) and Kerstin Lindell (member of the Board since 2014) have informed that they are not available for re-election. The Nomination Board further proposes that the Annual General Meeting resolves to elect Reima Kerttula as Chairman of the Board of Directors and Matti Hyytiäinen as the Vice Chairman of the Board of Directors for the term ending at the closure of the Annual General Meeting of 2017. 

All nominees have given their consent for the election. The presentation of persons proposed for Exel Composites Plc's Board of Directors can be found on the Company’s website at www.exelcomposites.com .

Remuneration of the Board of Directors The Nomination Board proposes to the Annual General Meeting of 19 March 2016 that the annual remuneration for the Board members shall be as follows: Yearly remuneration of EUR 36,000 (previous year EUR 36,000) for the Chairman of the Board of Directors and additionally EUR 1,500 for attendance at Board and committee meetings and other similar Board assignments, yearly remuneration of EUR 27,000 for the Vice Chairman of the Board of Directors and additionally EUR 1,250 for attendance at Board and committee meetings and other similar Board assignments and the other Board members be paid a yearly remuneration of EUR 18,000 (previous year EUR 18,000) and additionally EUR 1,000 for attendance at Board and committee meetings and other similar Board assignments. 

Out of the yearly remuneration 60 per cent would be paid in cash and 40 per cent in Exel Composites Plc shares, which would be acquired directly for and on behalf of the members of the Board of Directors during 21 March – 8 April 2016 from the stock exchange market in amounts corresponding to EUR 14,400 for the Chairman, EUR 10,800 for the Vice Chairman and EUR 7,200 for each of the other members. The annual remuneration shall encompass the full term of office of the Board of Directors. If the required amount of shares cannot be acquired during the specified period in accordance with applicable rules and regulations, the part of yearly remuneration to be paid in shares which could not be acquired can be paid in cash. Should the term of any member of the Board of Directors come to an end for whatever reason before the next Annual General Meeting, such member of the Board of Directors will have to return to the Company the remuneration or equivalent amount in cash already received but not yet earned at that point in time.

The Nomination Board also proposes that travel expenses and other out-of-pocket expenses arising from the Board work be compensated in accordance with the Company’s established practice and travel rules. The Nomination Board comprises four members nominated by the largest shareholders, and the Chairman of the Board of Directors, acting as an expert member. The largest shareholders of the Company were determined on the basis of the shareholdings registered in the Finnish book-entry system on 1 October 2015. The composition of the Nomination Board preparing the proposal for the Annual General Meeting 2016 is the following:

Ted Roberts, Chairman (Nordea) Tuomas Virtala (Danske Invest) Henrik Viktorsson (Alandia Insurance) Kalle Saariaho (OP Financial Group) Peter Hofvenstam (Chairman of the Board of Directors)

Vantaa, 1 February 2016 EXEL COMPOSITES PLC   

Riku Kytömäki President and CEO

For further information please contact: Ted Roberts, Chairman of the Nomination Board, tel. +358 400 846 046, email: ted.roberts@nordea.com

Distribution: Nasdaq Helsinki Ltd Main news media www.exelcomposites.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 225

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 321

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 391

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading

Top 5 Most Recently Viewed Articles

Embrace Pet Insurance Breaks Records in Volunteerism and Giving

Updated Category News Views 317

Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...

Continue Reading
Sony's Innovative OLED Microdisplay Sets New Industry Standards

Updated Category News Views 210

Exploring Sony's Innovative OLED Technology Sony Semiconductor Solutions Corporation is about to change the landscape of augmented reality (AR) with the introduction of its groundbreaking ECX350F. This 0.44-type Full HD OLED Microdisplay is remarkable for its unique features, including the smallest pixel size in the industry and outstanding brightness. This innovation...

Continue Reading
Bascom Palmer Eye Institute Claims Top Spot in Medical Rankings

Updated Category News Views 269

Bascom Palmer Eye Institute's Unrivaled Recognition in 2025 For an impressive 24th consecutive year, Bascom Palmer Eye Institute has been honored as the premier ophthalmology hospital in the United States. This prestigious recognition, detailed in the 2025 U.S. News & World Report "Best Hospitals" rankings, underscores the institute's unwavering commitment to providing...

Continue Reading
Insights on Unusual Options Activity for Alphabet Inc.

Updated Category News Views 269

Unusual Options Activity Analysis for Alphabet Inc. Recent trends indicate that prominent financial players are adopting a bearish stance on Alphabet Inc. Our thorough analysis of options history for Alphabet (GOOGL) highlights 20 unusual trades, emphasizing a notable shift in market sentiment. Understanding Trader Sentiment Upon delving into the trade specifics, our...

Continue Reading
A Critical Juncture for uniQure Amidst Regulatory Challenges

Updated Category News Views 191

uniQure's Recent FDA Feedback The U.S. Food and Drug Administration (FDA) recently provided important insights to uniQure N.V. (NASDAQ: QURE) about its proposed gene therapy for Huntington’s disease. This feedback has led to a noticeable drop in the company’s stock price, reflecting heightened investor concern. Understanding AMT-130 AMT-130 is uniQure’s...

Continue Reading